- Home
- GOF vs PBH Comparison
GOF vs PBH Comparison
Compare GOF & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GOF | PBH |
|---|---|---|
| Founded | N/A | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.4B |
| IPO Year | 2006 | 2004 |
Fundamental Metrics
Financial Performance| Metric | GOF | PBH |
|---|---|---|
| Price | $9.37 | $52.28 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $75.33 |
| AVG Volume (30 Days) | ★ 3.0M | 516.0K |
| Earning Date | 01-01-0001 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.61 |
| Revenue | N/A | ★ $975,777,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.31 |
| P/E Ratio | ★ N/A | $86.02 |
| Revenue Growth | N/A | ★ 36.77 |
| 52 Week Low | $8.96 | $42.62 |
| 52 Week High | $15.16 | $71.07 |
Technical Indicators
Market Signals| Indicator | GOF | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 25.36 | 52.43 |
| Support Level | $8.96 | $50.49 |
| Resistance Level | $10.88 | $52.34 |
| Average True Range (ATR) | 0.27 | 1.44 |
| MACD | -0.06 | -0.07 |
| Stochastic Oscillator | 22.75 | 43.89 |
Price Performance
Historical ComparisonAbout GOF Guggenheim Strategic Opportunities Fund of Beneficial Interest
Guggenheim Strategic Opportunities Fund is a diversified, closed-end management investment company. The Fund's investment objective is to maximize total return through a combination of current income and capital appreciation. It has single operating segment. Its products are Mutual Funds, Wealth Management SMAS, Institutional SMAS, ETFS, UITS, UCITS, CIT, Closed-End Funds, Private Funds, Rydex Funds, and Variable Insurance funds.
About PBH Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.